Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global ELECTRONIC TRIAL MASTER FILE (ETMF) market in this environment.
In terms of revenue, this research report indicated that the global ELECTRONIC TRIAL MASTER FILE (ETMF) market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of ELECTRONIC TRIAL MASTER FILE (ETMF) industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The BIOVIA Corp aims at producing XX ELECTRONIC TRIAL MASTER FILE (ETMF) in 2020, with XX % production to take place in global market, LabCorp accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of ELECTRONIC TRIAL MASTER FILE (ETMF) Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in ELECTRONIC TRIAL MASTER FILE (ETMF) Market?
BIOVIA Corp
LabCorp
CareLex
SAFE-BioPharma
Wingspan Technology
Mayo Clinic
arivis AG
Aurea Software
Veeva Systems
NCGS
ePharmaSolutions
TransPerfect Global
PharmaVigilant
Montrium
MasterControl
Forte Research
Phlexglobal Limited
Dell EMC
Freyr
SureClinical
SterlingBio
Paragon Solutions
Ennov
Oracle Corporation
Database Integrations
...
Major Type of ELECTRONIC TRIAL MASTER FILE (ETMF) Covered in XYZResearch report:
On Premise
Cloud
Application Segments Covered in XYZResearch Market
Pharmaceutical Company
Biotechnology Company Contract research organization
Contract Research Organization
For any other requirements, please feel free to contact us and we will provide you customized report.
Request Sample 
Request Discount 
Inquire Before BuyTable of Contents
Global ELECTRONIC TRIAL MASTER FILE (ETMF) Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 On Premise -Product Introduction and Major Manufacturers
1.1.2 Cloud -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global ELECTRONIC TRIAL MASTER FILE (ETMF) Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.1.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.2.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.3.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.4.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.5.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.6.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America ELECTRONIC TRIAL MASTER FILE (ETMF) Market
3.7.1 Top Companies leading ELECTRONIC TRIAL MASTER FILE (ETMF) Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America ELECTRONIC TRIAL MASTER FILE (ETMF) Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 ELECTRONIC TRIAL MASTER FILE (ETMF) Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on ELECTRONIC TRIAL MASTER FILE (ETMF) Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global ELECTRONIC TRIAL MASTER FILE (ETMF) Sales and Growth Rate (2021-2026)
5.2 Global ELECTRONIC TRIAL MASTER FILE (ETMF) Sales Value and Growth Rate (2021-2026)
6 ELECTRONIC TRIAL MASTER FILE (ETMF) Competitive Analysis
6.1 BIOVIA Corp
6.1.1 BIOVIA Corp Company Profiles
6.1.2 BIOVIA Corp Product Introduction
6.1.3 BIOVIA Corp ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 LabCorp
6.2.1 LabCorp Company Profiles
6.2.2 LabCorp Product Introduction
6.2.3 LabCorp ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 CareLex
6.3.1 CareLex Company Profiles
6.3.2 CareLex Product Introduction
6.3.3 CareLex ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 SAFE-BioPharma
6.4.1 SAFE-BioPharma Company Profiles
6.4.2 SAFE-BioPharma Product Introduction
6.4.3 SAFE-BioPharma ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Wingspan Technology
6.5.1 Wingspan Technology Company Profiles
6.5.2 Wingspan Technology Product Introduction
6.5.3 Wingspan Technology ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Mayo Clinic
6.6.1 Mayo Clinic Company Profiles
6.6.2 Mayo Clinic Product Introduction
6.6.3 Mayo Clinic ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 arivis AG
6.7.1 arivis AG Company Profiles
6.7.2 arivis AG Product Introduction
6.7.3 arivis AG ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Aurea Software
6.8.1 Aurea Software Company Profiles
6.8.2 Aurea Software Product Introduction
6.8.3 Aurea Software ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Veeva Systems
6.9.1 Veeva Systems Company Profiles
6.9.2 Veeva Systems Product Introduction
6.9.3 Veeva Systems ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 NCGS
6.10.1 NCGS Company Profiles
6.10.2 NCGS Product Introduction
6.10.3 NCGS ELECTRONIC TRIAL MASTER FILE (ETMF) Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 ePharmaSolutions
6.12 TransPerfect Global
6.13 PharmaVigilant
6.14 Montrium
6.15 MasterControl
6.16 Forte Research
6.17 Phlexglobal Limited
6.18 Dell EMC
6.19 Freyr
6.20 SureClinical
6.21 SterlingBio
6.22 Paragon Solutions
6.23 Ennov
6.24 Oracle Corporation
6.25 Database Integrations
7 Conclusion
| Price : US$ 3500 | Date : Dec 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 162 |
| Price : US$ 3500 | Date : Dec 2024 |
| Category : Chemicals and Materials | Pages : 162 |
| Price : US$ 3500 | Date : Dec 2024 |
| Category : Services | Pages : 167 |
| Price : US$ 3500 | Date : Dec 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 129 |
| Price : US$ 3500 | Date : Dec 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 218 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
